Renilla-Firefly Luciferase Dual Assay Kit
Based on 40 publication(s) in Google Scholar
MCE Renilla-Firefly Luciferase Dual Assay Kit is designed to be used for high-throughput, rapid quantitation of both Firefly and Renilla luciferases from a single sample in mammalian cell culture.
-
Storage :
-20℃, 1 year. Protecting from light.
Description & Advantages
MCE Renilla-Firefly Luciferase Dual Assay Kit contains high-purity D-Luciferin, coelenterazine and proprietary reaction buffer. The Firefly Luciferase Working Solution is first added to the sample. This reagent contains D-Luciferin which can produce Firefly luciferase bioluminescence. Next, the Renilla Luciferase Working Solution is added to the same sample. It quenches the Firefly luciferase bioluminescence and produce Renilla luciferase bioluminescence. The light production of both reactions can be conveniently measured on a luminometer.
Protocol
1. Material Preparation
1.1 Preparation of Lysis Buffer (1×)
Dilute Lysis Buffer (5×) 1:5 with dH2O (e.g. 1 mL Lysis Buffer + 4 mL dH2O)
1.2 Preparation of Firefly Luciferase Working Solution
Briefly centrifuge the Firefly Luciferase Substrate before opening the tube. Add 1 mL of Firefly Luciferase Buffer and mix thoroughly. Transfer the entire solution to the remaining 9 mL of Firefly Luciferase Buffer and mix well to obtain the working solution.
1.3 Preparation of Renilla Luciferase Working Solution
Briefly centrifuge the Renilla Luciferase Substrate before opening the tube. Add 1 mL of Renilla Luciferase Buffer and mix thoroughly. Transfer the entire solution to the remaining 9 mL of Renilla Luciferase Buffer and mix well to obtain the working solution.
Note: Firefly Luciferase Working Solution and Renilla Luciferase Working Solution can be dispensed into aliquots. When protecting from light and avoiding repetitive freeze-thaw cycles, the reagent is stable for one month at -20°C or for one year when stored at -80°C.
2. Cell Lysis
2.1 Determine transfection parameters (plated cell density and subsequent incubation time) to ensure that cells are no more than 95% confluent at the desired time of lysate preparation.
2.2 Carefully remove culture medium from cells. Wash cells with wash solution, such as PBS, normal saline orserum-free culture medium, to remove residual medium.
2.3 Add proper volume of Lysis Buffer (1×). The recommended volumes of Lysis Buffer (1×) to add per well are as follows:
| Multi-well Plate | Lysis Buffer/Well |
|---|---|
| 6-well | 500 μL |
| 12-well | 200 μL |
| 24-well | 100 μL |
| 48-well | 50 μL |
| 96-well | 30 μL |
Note: The volume of added Lysis Buffer (1×) can be adjusted proportionally.
2.4 Add proper volume of Lysis Buffer (1×). The recommended volumes of Lysis Buffer (1×) to add per well are as follows:
2.5 Place the culture plates on a shaker with gentle shaking at room temperature for 15 minutes.
2.6 After lysis, centrifuge at 12,000 rpm for 10 minutes at 4 °C. Transfer the supernatants to a new tube for further analysis.
3. Luciferase Dual Assay
3.1 Add 20μL of cell lysate to a black flat-bottomed 96-well plate.
3.2 Add 100 μL of Firefly Luciferase Working Solution into each well containing cell lysate.
3.3 Immediately after adding the reagent, read the sample to capture the Firefly luciferase signals.
3.4 Add 100 μL of Renilla Luciferase Working Solution into each well from step 3.3, then immediately read the sample again to capture the Renilla luciferase signals.
3.5 Calculate the ratio of luminescence from the Firefly luciferase to the Renilla luciferase.
Note: 1) Assure Firefly Luciferase Working Solution and Renilla Luciferase Working Solution are equilibrated to room temperature before use.
2) The luminescence values of Firefly and Renilla Luciferase should be subtracted from the corresponding background values.
Publications
-
Journal Impact Factor
-
Most Recent
-
Nat CommunResistance to anti-LAG-3 plus anti-PD-1 therapy in head and neck cancer is mediated by Sox9+ tumor cells interaction with Fpr1+ neutrophils. [Abstract]2025 Apr 28;16(1):3975. PMID: 40295483
Renilla-Firefly Luciferase Dual Assay Kit purchased from MedChemExpress. Usage Cited in: Nat Commun. 2025 Apr 28;16(1):3975. [Abstract]
The relative activity of the Anxa1 promoter was detected via luciferase assay in three groups. All experiments were independently repeated in triplicate. Luciferase activity results showed that Sox9 overexpression significantly activated Anxa1 gene transcription in Moc1 cells transfected with the reporter construct. Motif deletion abolished this induction of the Anxa1 promoter. The Renilla-Firefly Luciferase Dual Assay Kit was used for the detection and analysis of luciferase activity.
-
Cell DiscovIGF2BP3-dependent glutamine/BCAA metabolic rewiring rejuvenates aged human adipose-derived stem cells for enhanced tissue regeneration. [Abstract]2026 Jan 20;12(1):5. PMID: 41559031
Renilla-Firefly Luciferase Dual Assay Kit purchased from MedChemExpress. Usage Cited in: Cell Discov. 2026 Jan 20;12(1):5. [Abstract]
Luciferase activities of WT or Mut BCAT1 and GLS reporter vectors were quantified in I-hASCs under defined genetic perturbations: control, IGF2BP3 overexpression (IGF2BP3), or IGF2BP3 overexpression with METTL3 knockdown (IGF2BP3+shMETTL3). Luciferase activity was quantified using the Renilla-Firefly Luciferase Dual Assay Kit.
-
J Clin InvestThe CTBP2-PCIF1 complex regulates m6Am modification of mRNA in head and neck squamous cell carcinoma. [Abstract]2023 Oct 16;133(20):e170173. PMID: 37643007
Renilla-Firefly Luciferase Dual Assay Kit purchased from MedChemExpress. Usage Cited in: J Clin Invest. 2023 Oct 16;133(20):e170173. [Abstract]
Luciferase activity of TET2 5′-UTR WT or TET2 5′-UTR m6Am site mutation (5′-UTR MUT) in SCC1 control cells and cells transfected with WT (OE) or mutant PCIF1 plasmid (OEmut) (n = 3). Luciferase activity was quantified using the Renilla-Firefly Luciferase Dual Assay Kit.
-
Cell Rep MedDDX5 super-enhancer promotes vasculogenic mimicry formation and metastasis in nasopharyngeal carcinoma by enhancing ADAM10 transcription. [Abstract]2025 Jun 17;6(6):102146. PMID: 40412383
Renilla-Firefly Luciferase Dual Assay Kit purchased from MedChemExpress. Usage Cited in: Cell Rep Med. 2025 Jun 17;6(6):102146. [Abstract]
Luciferase reporter assay to confirm the transcriptional activation of ADAM10 by DDX5 and E2F1 (3 independent experiments). Luciferase activity was quantified using the Renilla-Firefly Luciferase Dual Assay Kit.
-
J Transl MedBioinformatics analysis and experimental validation of potential targets and pathways in chronic kidney disease associated with renal fibrosis. [Abstract]2025 Apr 2;23(1):387. PMID: 40176090
Renilla-Firefly Luciferase Dual Assay Kit purchased from MedChemExpress. Usage Cited in: J Transl Med. 2025 Apr 2;23(1):387. [Abstract]
Luciferase activity was quantified using the Renilla-Firefly Luciferase Dual Assay Kit. Relative luciferase activity. **P < 0.05 vs. Group (TGF-β1+, miR-223-3p-, CHUK plasmid-). **** P < 0.01 vs. Group (TGF-β1+, miR-223-3p-, CHUK plasmid-). The results of double luciferase reporter gene experiment showed that the relative activity of luciferase decreased significantly (P<0.01) after co-transfection of miR-223-3p mimics and wild-type CHUK vector, while co-transfected miR-223-3p mimics and mutant CHUK vectors showed no significant effect on the relative activity of luciferase (P>0.05), indicating that miR-223-3p could target IKKα mRNA to inhibit downstream NF-κB signaling pathway and suppress the EMT of HK2 cells.
-
OncogeneGSK3β and UCHL3 govern RIPK4 homeostasis via deubiquitination to enhance tumor metastasis in ovarian cancer. [Abstract]2024 Jun;43(25):1885-1899. PMID: 38664501
-
Am J PatholSCG2 Transcriptionally Activated by SP1 Promotes Nasal Epithelial Cell Proliferation and Epithelial Mesenchymal Transition. [Abstract]2025 Sep 12:S0002-9440(25)00333-5. PMID: 40946800
-
J Biochem Mol Toxicol2025 Feb;39(2):e70159. PMID: 39932071
-
Kaohsiung J Med Sci2025 Jun;41(6):e70028. PMID: 40289764
-
HeliyonDNMT3A-mediated DNA methylation and transcription inhibition of FZD5 suppresses lung carcinogenesis. [Abstract]2024 Apr 16;10(9):e29733. PMID: 38707304
-
HeliyonFunctional investigation of a novel ANKRD11 frameshift variant identified in a Chinese family with KBG syndrome. [Abstract]2024 Mar 13;10(6):e28082. PMID: 38515699
Storage
-20℃, 1 year.
Protecting from light.
Components
| Components | HY-K1013-100T |
|---|---|
| Firefly Luciferase Buffer | 10 mL |
| Firefly Luciferase Substrate | 1 vial |
| Renilla Luciferase Buffer | 10 mL |
| Renilla Luciferase Substrate | 1 vial |
| Lysis Buffer (5×) | 10 mL |